Serum long-chain n-3 polyunsaturated fatty acids, mercury, and risk of sudden cardiac death in men: A prospective population-based study

PLoS ONE

Volumn 7, Issue 7, 2012, Pages

  Virtanen, Jyrki K ^a   Laukkanen, Jari A ^a   Mursu, Jaakko ^a   Voutilainen, Sari ^a   Tuomainen, Tomi Pekka ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

DOCOSAHEXAENOIC ACID; LONG CHAIN N 3 POLYUNSATURATED FATTY ACID; MERCURY; OMEGA 3 FATTY ACID; UNCLASSIFIED DRUG;

ADULT; ARTICLE; FAT INTAKE; FATTY ACID BLOOD LEVEL; HAIR LEVEL; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SUDDEN DEATH;

ADULT; DEATH, SUDDEN, CARDIAC; DOCOSAHEXAENOIC ACIDS; EICOSAPENTAENOIC ACID; FATTY ACIDS, UNSATURATED; HAIR; HUMANS; MALE; MERCURY; MIDDLE AGED; MODELS, STATISTICAL; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK;

EID: 84864007236     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0041046     Document Type: Article

References (47)

1. Mozaffarian D, Rimm EB, (2006) Fish intake, contaminants, and human health: evaluating the risks and the benefits. JAMA 296: 1885-1899.
2. Huikuri HV, Castellanos A, Myerburg RJ, (2001) Sudden death due to cardiac arrhythmias. N Engl J Med 345: 1473-1482.
3. Kang JX, Leaf A, (1994) Effects of long-chain polyunsaturated fatty acids on the contraction of neonatal rat cardiac myocytes. Proc Natl Acad Sci U S A 91: 9886-9890.
4. Billman GE, Kang JX, Leaf A, (1999) Prevention of sudden cardiac death by dietary pure omega-3 polyunsaturated fatty acids in dogs. Circulation 99: 2452-2457.
5. McLennan PL, (2001) Myocardial membrane fatty acids and the antiarrhythmic actions of dietary fish oil in animal models. Lipids 36.
6. Siscovick DS, Raghunathan TE, King I, Weinmann S, Wicklund KG, et al. (1995) Dietary intake and cell membrane levels of long-chain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest. JAMA 274: 1363-1367.
7. Albert CM, Hennekens CH, O'Donnell CJ, Ajani UA, Carey VJ, et al. (1998) Fish consumption and risk of sudden cardiac death. JAMA 279: 23-28.
8. Mozaffarian D, Lemaitre RN, Kuller LH, Burke GL, Tracy RP, et al. (2003) Cardiac benefits of fish consumption may depend on the type of fish meal consumed: the Cardiovascular Health Study. Circulation 107: 1372-1377.
9. Mozaffarian D, Ascherio A, Hu FB, Stampfer MJ, Willett WC, et al. (2005) Interplay between different polyunsaturated fatty acids and risk of coronary heart disease in men. Circulation 111: 157-164.
10. Streppel MT, Ocke MC, Boshuizen HC, Kok FJ, Kromhout D, (2008) Long-term fish consumption and n-3 fatty acid intake in relation to (sudden) coronary heart disease death: the Zutphen study. Eur Heart J 29: 2024-2030.
11. Wennberg M, Bergdahl IA, Hallmans G, Norberg M, Lundh T, et al. (2011) Fish consumption and myocardial infarction: a second prospective biomarker study from northern Sweden. Am J Clin Nutr 93: 27-36.
12. Albert CM, Campos H, Stampfer MJ, Ridker PM, Manson JE, et al. (2002) Blood levels of long-chain n-3 fatty acids and the risk of sudden death. N Engl J Med 346: 1113-1118.
13. Burr ML, Fehily AM, Gilbert JF, Rogers S, Holliday RM, et al. (1989) Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet 2: 757-761.
14. Marchioli R, (1999) Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet 354: 447-455.
15. Burr ML, Ashfield-Watt PA, Dunstan FD, Fehily AM, Breay P, et al. (2003) Lack of benefit of dietary advice to men with angina: results of a controlled trial. Eur J Clin Nutr 57: 193-200.
16. Kromhout D, Giltay EJ, Geleijnse JM, Alpha Omega Trial Group (2010) N-3 fatty acids and cardiovascular events after myocardial infarction. N Engl J Med 363: 2015-2026.
17. Salonen JT, Seppanen K, Nyyssonen K, Korpela H, Kauhanen J, et al. (1995) Intake of mercury from fish, lipid peroxidation, and the risk of myocardial infarction and coronary, cardiovascular, and any death in eastern Finnish men. Circulation 91: 645-655.
18. Virtanen JK, Voutilainen S, Rissanen TH, Mursu J, Tuomainen TP, et al. (2005) Mercury, fish oils, and risk of acute coronary events and cardiovascular disease, coronary heart disease, and all-cause mortality in men in eastern Finland. Arterioscler Thromb Vasc Biol 25: 228-233.
19. Guallar E, Sanz-Gallardo MI, van't Veer P, Bode P, Aro A, et al. (2002) Mercury, fish oils, and the risk of myocardial infarction. N Engl J Med 347: 1747-1754.
20. Hallgren CG, Hallmans G, Jansson JH, Marklund SL, Huhtasaari F, et al. (2001) Markers of high fish intake are associated with decreased risk of a first myocardial infarction. Br J Nutr 86: 397-404.
21. Mozaffarian D, Shi P, Morris JS, Spiegelman D, Grandjean P, et al. (2011) Mercury exposure and risk of cardiovascular disease in two U.S. cohorts. N Engl J Med 364: 1116-1125.
22. Salonen JT, (1988) Is there a continuing need for longitudinal epidemiologic research? The Kuopio Ischaemic Heart Disease Risk Factor Study. Ann Clin Res 20: 46-50.
23. Salonen JT, Nyyssonen K, Korpela H, Tuomilehto J, Seppanen R, et al. (1992) High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men. Circulation 86: 803-811.
24. Lakka TA, Venäläinen JM, Rauramaa R, Salonen R, Tuomilehto J, et al. (1994) Relation of leisure-time physical activity and cardiorespiratory fitness to the risk of acute myocardial infarction. N Engl J Med 330: 1549-1554.
25. Voutilainen S, Rissanen TH, Virtanen J, Lakka TA, Salonen JT, (2001) Low dietary folate intake is associated with an excess incidence of acute coronary events: The Kuopio Ischemic Heart Disease Risk Factor Study. Circulation 103: 2674-2680.
26. Laaksonen DE, Lakka TA, Lakka HM, Nyyssonen K, Rissanen T, et al. (2002) Serum fatty acid composition predicts development of impaired fasting glycaemia and diabetes in middle-aged men. Diabet Med 19: 456-464.
27. Tunstall-Pedoe H, Kuulasmaa K, Amouyel P, Arveiler D, Rajakangas AM, et al. (1994) Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents. Circulation 90: 583-612.
28. Virtanen JK, Mursu J, Voutilainen S, Tuomainen TP, (2009) Serum long-chain n-3 polyunsaturated fatty acids and risk of hospital diagnosis of atrial fibrillation in men. Circulation 120: 2315-2321.
29. McLennan P, Howe P, Abeywardena M, Muggli R, Raederstorff D, et al. (1996) The cardiovascular protective role of docosahexaenoic acid. Eur J Pharmacol 300: 83-89.
30. Mori TA, Bao DQ, Burke V, Puddey IB, Beilin LJ, (1999) Docosahexaenoic acid but not eicosapentaenoic acid lowers ambulatory blood pressure and heart rate in humans. Hypertension 34: 253-260.
31. Grimsgaard S, Bonaa KH, Hansen JB, Myhre ES, (1998) Effects of highly purified eicosapentaenoic acid and docosahexaenoic acid on hemodynamics in humans. Am J Clin Nutr 68: 52-59.
32. Christensen JH, Gustenhoff P, Korup E, Aaroe J, Toft E, et al. (1996) Effect of fish oil on heart rate variability in survivors of myocardial infarction: a double blind randomised controlled trial. BMJ 312: 677-678.
33. Christensen JH, Christensen MS, Dyerberg J, Schmidt EB, (1999) Heart rate variability and fatty acid content of blood cell membranes: a dose-response study with n-3 fatty acids. Am J Clin Nutr 70: 331-337.
34. Kleiger RE, Stein PK, Bigger JT Jr, (2005) Heart rate variability: measurement and clinical utility. Ann Noninvasive Electrocardiol 10: 88-101.
35. Arterburn LM, Hall EB, Oken H, (2006) Distribution, interconversion, and dose response of n-3 fatty acids in humans. Am J Clin Nutr 83: 1467S-1476S.
36. Brouwer IA, Raitt MH, Dullemeijer C, Kraemer DF, Zock PL, et al. (2009) Effect of fish oil on ventricular tachyarrhythmia in three studies in patients with implantable cardioverter defibrillators. Eur Heart J 30: 820-826.
37. Roman HA, Walsh TL, Coull BA, Dewailly E, Guallar E, et al. (2011) Evaluation of the cardiovascular effects of methylmercury exposures: Current evidence supports development of a dose-response function for regulatory benefits analysis. Environ Health Perspect. 119: 607-614.
38. Schlawicke Engstrom K, Stromberg U, Lundh T, Johansson I, Vessby B, et al. (2008) Genetic variation in glutathione-related genes and body burden of methylmercury. Environ Health Perspect 116: 734-739.
39. Mozaffarian D, Geelen A, Brouwer IA, Geleijnse JM, Zock PL, et al. (2005) Effect of fish oil on heart rate in humans: a meta-analysis of randomized controlled trials. Circulation 112: 1945-1952.
40. Mozaffarian D, Stein PK, Prineas RJ, Siscovick DS, (2008) Dietary fish and omega-3 fatty acid consumption and heart rate variability in US adults. Circulation 117: 1130-1137.
41. Virtanen JK, Rissanen TH, Voutilainen S, Tuomainen TP, (2007) Mercury as a risk factor for cardiovascular diseases. J Nutr Biochem 18: 75-85.
42. Fukuda K, Davies SS, Nakajima T, Ong BH, Kupershmidt S, et al. (2005) Oxidative mediated lipid peroxidation recapitulates proarrhythmic effects on cardiac sodium channels. Circ Res 97: 1262-1269.
43. Clarkson TW, Magos L, (2006) The toxicology of mercury and its chemical compounds. Crit Rev Toxicol 36: 609-662.
44. Nikkari T, Luukkainen P, Pietinen P, Puska P, (1995) Fatty acid composition of serum lipid fractions in relation to gender and quality of dietary fat. Ann Med 27: 491-498.
45. Hunter D, (1998) Biochemical indicators of dietary intake. In: Willett W, editors. pp. 174-243 editor. Nutritional Epidemiology. New York, NY: Oxford University Press.
46. World Health Organization (1990) International Programme on Chemical Safety (IPCS). Environmental Health Criteria 101: Methylmercury. Geneva, Switzerland.
47. Groth E III, (2010) Ranking the contributions of commercial fish and shellfish varieties to mercury exposure in the United States: Implications for risk communication. Environ Res 110: 226-236.